September 3rd 2024
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
August 23rd 2024
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.
August 22nd 2024
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
August 19th 2024
The First to Know Syphilis Test detects a current or past infection, regardless of successful treatment, in 15 minutes using a drop of blood.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 25, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Monkeypox: What We Know About the Outbreak Now
The CDC reported 1 confirmed case of monkeypox in Massachusetts on May 23rd; Quebec is investigating 17 suspected cases. Find out what we know now about the virus.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 24, 2022
FDA Grants EUA for At-home Triple Test: COVID-19, Influenza, RSV
The Labcorp home test, available without a prescription, is delivered overnight and includes a return envelope. Results are available in 1-2 days.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 23, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 20, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 18, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 17, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 16, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 12, 2022
Shingrix: Who Needs It and Who Doesn't?
A 55-year-old healthy man has a rash on his back that is diagnosed as shingles. He has never received any shingles vaccine–is he eligible now? Plus 3 more patient scenarios.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 11, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 10, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 9, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 4, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 2, 2022
Remdesivir Wins FDA Approval for Treatment of COVID-19 in Youngest Patients
The US FDA expanded approval of remdesivir this week to include pediatric patients aged 28 days and older, the first COVID-19 treatment indicated for this population.
Moderna Announces Filing for Emergency Use Authorization for its COVID-19 Vaccine in Children Under Age 6 Years
The biotechnology company said on Thursday that similar requests are underway with international regulatory authorities.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 27, 2022
COVID-19 Epilogue: 10 Lessons Learned During 2 Long Years
Infectious disease expert and clinical investigator Rodger MacArthur, MD, considers what we know now that we didn't on March 12, 2020.
7 Questions on Latest US STD Trends
SAMPLE: Between 2019 and 2020, the rate of reported gonorrhea increased 10%. True or false? Plus, 6 more questions based on the CDC’s 2020 STD Surveillance Report.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 21, 2022
Preliminary Results Support Feasibility, Immunogenicity of Influenza-COVID-19 Combo Vaccine
Novavax reports that the various combinations assessed were safe and induced immune responses comparable to stand-alone formulations of both vaccines.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 20, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 19, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 18, 2022
FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples
The FDA recently announced it had issued an emergency use authorization for the first COVID-19 diagnostic test that detects chemical compounds in breath samples associated with SARS-CoV-2 infection.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 14, 2022